Kura Oncology, Inc. (KURA)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Dr. Troy Edward Wilson J.D., Ph.D.
|
Chairman, CEO & President | 1.44M | -- | 1969 |
|
Ms. Kathleen Ford
|
Chief Operating Officer | 926.5k | -- | 1947 |
|
Mr. Brian T. Powl M.B.A., M.S.
|
Chief Commercial Officer | 815k | -- | 1974 |
|
Ms. Jennifer Fulk
|
Chief Financial Officer | -- | -- | 1977 |
|
Mr. Thomas Doyle
|
Senior Vice President of Finance & Accounting | -- | -- | 1971 |
|
Dr. Francis J. Burrows Ph.D.
|
Chief Scientific Officer | -- | -- | 1962 |
|
Mr. Greg Mann
|
Senior Vice President of Investor Relations & Corporate Affairs | -- | -- | -- |
|
Ms. Teresa Brophy Bair Esq., J.D.
|
Chief Legal Officer & Corporate Secretary | 745.02k | -- | 1971 |
|
Dr. Roger Bakale Ph.D.
|
Senior Vice President of Manufacturing & Supply Chain | -- | -- | -- |
|
Dr. Mollie Leoni M.D.
|
Chief Medical Officer | -- | -- | 1978 |
Kura Oncology, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 260
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
Corporate Governance
Upcoming Events
November 3, 2026 at 8:00 PM UTC
Kura Oncology, Inc. Earnings Date
